Acadia Pharmaceuticals buy UBS Group AG
Start price
08.08.25
/
50%
€21.15
Target price
08.08.26
€30.87
Performance (%)
9.36%
Price
12.12.25
€23.13
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 9.36%. This prediction currently runs until 08.08.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -1.867% | -1.867% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by UBS_Group_AG for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was given a new $36.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by UBS_Group_AG for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€23.27
04.12.25
04.12.25
-
04.12.26
04.12.26
-0.60%
12.12.25
12.12.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.96
09.09.25
09.09.25
€33.13
09.09.26
09.09.26
10.35%
12.12.25
12.12.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.56
08.08.24
08.08.24
€21.10
08.08.25
08.08.25
43.94%
09.08.25
09.08.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.80
17.10.23
17.10.23
€31.28
17.10.24
17.10.24
-36.33%
18.10.24
18.10.24